[From the commentary “Novelty in science should not come at the cost of reproducibility” by Andrew Holding, published in The FEBS Journal] “Oestrogen receptor (ER) cycling is a dogma of the Oestrogen receptor-positive (ER+) breast cancer field.” “For nearly 20…
Read More